Publications

• 1. Hostetler GL
  2. Barber CM
  3. Miklus MB
  4. Prieto PA
  Determination of Casein Allergens in Extensively Hydrolyzed Casein Infant Formula by Liquid Chromatography - Tandem Mass Spectrometry.; Journal of AOAC International. 2020 Oct 16.
• 1. Han BJ
  2. Murphy JD
  3. Qin S
  4. Ye J
  5. Uccello TP
  6. Garrett-Larsen J
  7. Belt BA
  8. Prieto PA
  9. Egilmez NK
  10. Lord EM
  11. Linehan DC
  12. Mills BN
  13. Gerber SA
  Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma.; Immunological investigations. 2020 Jun 04.
• 1. Esaa FS
  2. Hobson JG
  3. Matar RN
  4. Prieto PA
  5. Somers KE
  Toxic epidermal necrolysis after radiotherapy for pleomorphic liposarcoma.; Dermatology online journal; Vol 26(1). 2020 Jan 15.
• 1. Mills BN
  2. Connolly KA
  3. Ye J
  4. Murphy JD
  5. Uccello TP
  6. Han BJ
  7. Zhao T
  8. Drage MG
  9. Murthy A
  10. Qiu H
  11. Patel A
  12. Figueroa NM
  13. Johnston CJ
  14. Prieto PA
  15. Egilmez NK
  16. Belt BA
  17. Lord EM
  18. Linehan DC
  19. Gerber SA
  Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment.; Cell reports; Vol 29(2). 2019 Oct 08.
• 1. Amaria RN
  2. Menzies AM
  3. Burton EM
  4. Scolyer RA
  5. Tetzlaff MT
  6. Antdbacka R
  7. Ariyan C
  8. Bassett R
  9. Carter B
  10. Daud A
  11. Faries M
  12. Fecher LA
  13. Flaherty KT
  14. Gershenwald JE
  15. Hamid O
  16. Hong A
  17. Kirkwood JM
  18. Lo S
  19. Margolin K
  20. Messina J
  21. Postow MA
  22. Rizos H
  23. Ross MI
  24. Rozeman EA
  25. Saw RPM
  26. Sondak V
  27. Sullivan RJ
  28. Taube JM
  29. Thompson JF
  30. van de Wiel BA
  31. Eggermont AM
  32. Davies MA
  33. Ascierto PA
  34. Spillane AJ
  35. van Akkooi ACJ
  36. Wargo JA
  37. Blank CU
  38. Tawbi HA
  39. Long GV
  Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.; The Lancet. Oncology; Vol 20(7). 2019 Jul.
• 1. Patel AP
  2. Peacock JL
  3. Prieto PA
  High-grade angiosarcoma presenting with cytology-negative hemorrhagic ascites.; Journal of surgical case reports; Vol 2018(10). 2018 Oct.
• 1. Amaria RN
  2. Prieto PA
  3. Tetzlaff MT
  4. Reuben A
  5. Andrews MC
  6. Ross MI
  7. Glitza IC
  8. Cormier J
  9. Hwu WJ
  10. Tawbi HA
  11. Patel SP
  12. Lee JE
  13. Gershenwald JE
  14. Spencer CN
  15. Gopalakrishnan V
  16. Bassett R
  17. Simpson L
  18. Mouton R
  19. Hudgens CW
  20. Zhao L
  21. Zhu H
  22. Cooper ZA
  23. Wani K
  24. Lazar A
  25. Hwu P
  26. Diab A
  27. Wong MK
  28. McQuade JL
  29. Royal R
  30. Lucci A
  31. Burton EM
  32. Reddy S
  33. Sharma P
  34. Allison J
  35. Futreal PA
  36. Woodman SE
  37. Davies MA
  38. Wargo JA
  Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.; The Lancet. Oncology; Vol 19(2). 2018 Feb.
• 1. Gopalakrishnan V
  2. Spencer CN
  3. Nezi L
  4. Reuben A
  5. Andrews MC
  6. Karpinets TV
  7. Prieto PA
  8. Vicente D
  9. Hoffman K
  10. Wei SC
  11. Cogdill AP
  12. Zhao L
  13. Hudgens CW
  14. Hutchinson DS
  15. Manzo T
  16. Petaccia de Macedo M
  17. Cotechini T
  18. Kumar T
  19. Chen WS
  20. Reddy SM
  21. Szczepaniak Sloane R
  22. Galloway-Pena J
  23. Jiang H
  24. Chen PL
  25. Shpall EJ
  26. Rezvani K
  27. Alousi AM
  28. Chemaly RF
  29. Shelburne S
  30. Vence LM
  31. Okhuysen PC
  32. Jensen VB
  33. Swennes AG
  34. McAllister F
  35. Marcelo Riquelme Sanchez E
  36. Zhang Y
  37. Le Chatelier E
  38. Zitvogel L
  39. Pons N
  40. Austin-Breneman JL
  41. Haydu LE
  42. Burton EM
  43. Gardner JM
  44. Sirmans E
  45. Hu J
  46. Lazar AJ
  47. Tsujikawa T
  48. Diab A
  49. Tawbi H
  50. Glitza IC
  51. Hwu WJ
  52. Patel SP
  53. Woodman SE
  54. Amaria RN
  55. Davies MA
  56. Gershenwald JE
  57. Hwu P
  58. Lee JE
  59. Zhang J
  60. Coussens LM
  61. Cooper ZA
  62. Futreal PA
  63. Daniel CR
  64. Ajami NJ
  65. Petrosino JF
  66. Tetzlaff MT
  67. Sharma P
  68. Allison JP
  69. Jenq RR
  70. Wargo JA
  Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.; Science (New York, N.Y.); Vol 359(6371). 2018 Jan 05.
• 1. Mooradian MJ
  2. Reuben A
  3. Prieto PA
  4. Hazar-Rethinam M
  5. Frederick DT
  6. Nadres B
  7. Piris A
  8. Juneja V
  9. Cooper ZA
  10. Sharpe AH
  11. Corcoran RB
  12. Flaherty KT
  13. Lawrence DP
  14. Wargo JA
  15. Sullivan RJ
  A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.; Oncoimmunology; Vol 7(5). 2018.
• 1. Roh W
  2. Chen PL
  3. Reuben A
  4. Spencer CN
  5. Prieto PA
  6. Miller JP
  7. Gopalakrishnan V
  8. Wang F
  9. Cooper ZA
  10. Reddy SM
  11. Gumbs C
  12. Little L
  13. Chang Q
  14. Chen WS
  15. Wani K
  16. De Macedo MP
  17. Chen E
  18. Austin-Breneman JL
  19. Jiang H
  20. Roszik J
  21. Tetzlaff MT
  22. Davies MA
  23. Gershenwald JE
  24. Tawbi H
  25. Lazar AJ
  26. Hwu P
  27. Hwu WJ
  28. Diab A
  29. Glitza IC
  30. Patel SP
  31. Woodman SE
  32. Amaria RN
  33. Prieto VG
  34. Hu J
  35. Sharma P
  36. Allison JP
  37. Chin L
  38. Zhang J
  39. Wargo JA
  40. Futreal PA
  Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.; Science translational medicine; Vol 9(379). 2017 Mar 01.
• 1. Cogdill AP
  2. Prieto PA
  3. Reuben A
  4. Wargo JA
  Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper?; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 23(2). 2017 Jan 15.
• 1. Reuben A
  2. Spencer CN
  3. Prieto PA
  4. Gopalakrishnan V
  5. Reddy SM
  6. Miller JP
  7. Mao X
  8. De Macedo MP
  9. Chen J
  10. Song X
  11. Jiang H
  12. Chen PL
  13. Beird HC
  14. Garber HR
  15. Roh W
  16. Wani K
  17. Chen E
  18. Haymaker C
  19. Forget MA
  20. Little LD
  21. Gumbs C
  22. Thornton RL
  23. Hudgens CW
  24. Chen WS
  25. Austin-Breneman J
  26. Sloane RS
  27. Nezi L
  28. Cogdill AP
  29. Bernatchez C
  30. Roszik J
  31. Hwu P
  32. Woodman SE
  33. Chin L
  34. Tawbi H
  35. Davies MA
  36. Gershenwald JE
  37. Amaria RN
  38. Glitza IC
  39. Diab A
  40. Patel SP
  41. Hu J
  42. Lee JE
  43. Grimm EA
  44. Tetzlaff MT
  45. Lazar AJ
  46. Wistuba II
  47. Clise-Dwyer K
  48. Carter BW
  49. Zhang J
  50. Futreal PA
  51. Sharma P
  52. Allison JP
  53. Cooper ZA
  54. Wargo JA
  Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.; NPJ genomic medicine; Vol 2. 2017.
• 1. Christakis IA
  2. Potylchansky E
  3. Silva AM
  4. Nates JP
  5. Prieto PA
  6. Graham PH
  7. Grubbs EG
  8. Lee JE
  9. Perrier ND
  Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience.; Surgery; Vol 160(2). 2016 Aug.
• 1. Chen PL
  2. Roh W
  3. Reuben A
  4. Cooper ZA
  5. Spencer CN
  6. Prieto PA
  7. Miller JP
  8. Bassett RL
  9. Gopalakrishnan V
  10. Wani K
  11. De Macedo MP
  12. Austin-Breneman JL
  13. Jiang H
  14. Chang Q
  15. Reddy SM
  16. Chen WS
  17. Tetzlaff MT
  18. Broaddus RJ
  19. Davies MA
  20. Gershenwald JE
  21. Haydu L
  22. Lazar AJ
  23. Patel SP
  24. Hwu P
  25. Hwu WJ
  26. Diab A
  27. Glitza IC
  28. Woodman SE
  29. Vence LM
  30. Wistuba II
  31. Amaria RN
  32. Kwong LN
  33. Prieto V
  34. Davis RE
  35. Ma W
  36. Overwijk WW
  37. Sharpe AH
  38. Hu J
  39. Futreal PA
  40. Blando J
  41. Sharma P
  42. Allison JP
  43. Chin L
  44. Wargo JA
  Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.; Cancer discovery; Vol 6(8). 2016 Aug.
• 1. Starker LF
  2. Prieto PA
  3. Liles JS
  4. Tran Cao HS
  5. Grubbs EG
  6. Lee JE
  7. Perrier ND
  8. Graham PH
  Endocrine incidentalomas.; Current problems in surgery; Vol 53(5). 2016 May.
• 1. Cooper ZA
  2. Reuben A
  3. Spencer CN
  4. Prieto PA
  5. Austin-Breneman JL
  6. Jiang H
  7. Haymaker C
  8. Gopalakrishnan V
  9. Tetzlaff MT
  10. Frederick DT
  11. Sullivan RJ
  12. Amaria RN
  13. Patel SP
  14. Hwu P
  15. Woodman SE
  16. Glitza IC
  17. Diab A
  18. Vence LM
  19. Rodriguez-Canales J
  20. Parra ER
  21. Wistuba II
  22. Coussens LM
  23. Sharpe AH
  24. Flaherty KT
  25. Gershenwald JE
  26. Chin L
  27. Davies MA
  28. Clise-Dwyer K
  29. Allison JP
  30. Sharma P
  31. Wargo JA
  Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.; Oncoimmunology; Vol 5(3). 2016 Mar.
• 1. Prieto PA
  2. Reuben A
  3. Cooper ZA
  4. Wargo JA
  Targeted Therapies Combined With Immune Checkpoint Therapy.; Cancer journal (Sudbury, Mass.); Vol 22(2). 2016 Mar.
• 1. Lebastchi AH
  2. Prieto PA
  3. Chen C
  4. Lui FY
  Appendiceal endometriosis in a pregnant woman presenting with acute perforated appendicitis.; Journal of surgical case reports; Vol 2013(12). 2013 Dec 16.
• 1. Prieto PA
  2. Cha CH
  DKK1 as a serum biomarker for hepatocellular carcinoma.; Hepatobiliary surgery and nutrition; Vol 2(3). 2013 Jun.
• 1. Friedman KM
  2. Prieto PA
  3. Devillier LE
  4. Gross CA
  5. Yang JC
  6. Wunderlich JR
  7. Rosenberg SA
  8. Dudley ME
  Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.; Journal of immunotherapy (Hagerstown, Md. : 1997); Vol 35(5). 2012 Jun.
• 1. Prieto PA
  2. Yang JC
  3. Sherry RM
  4. Hughes MS
  5. Kammula US
  6. White DE
  7. Levy CL
  8. Rosenberg SA
  9. Phan GQ
  CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 18(7). 2012 Apr 01.
• 1. Langan RC
  2. Ripley RT
  3. Davis JL
  4. Prieto PA
  5. Datrice N
  6. Steinberg SM
  7. Bratslavsky G
  8. Rudloff U
  9. Kammula US
  10. Stojadinovic A
  11. Avital I
  Liver directed therapy for renal cell carcinoma.; Journal of Cancer; Vol 3. 2012.
• 1. Langan RC
  2. Prieto PA
  3. Sherry RM
  4. Zlott D
  5. Wunderlich J
  6. Csako G
  7. Costello R
  8. White DE
  9. Rosenberg SA
  10. Yang JC
  Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy.; Journal of immunotherapy (Hagerstown, Md. : 1997); Vol 34(4). 2011 May.
• 1. Dudley ME
  2. Gross CA
  3. Langhan MM
  4. Garcia MR
  5. Sherry RM
  6. Yang JC
  7. Phan GQ
  8. Kammula US
  9. Hughes MS
  10. Citrin DE
  11. Restifo NP
  12. Wunderlich JR
  13. Prieto PA
  14. Hong JJ
  15. Langan RC
  16. Zlott DA
  17. Morton KE
  18. White DE
  19. Laurencot CM
  20. Rosenberg SA
  CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 16(24). 2010 Dec 15.
• 1. Prieto PA
  2. Durflinger KH
  3. Wunderlich JR
  4. Rosenberg SA
  5. Dudley ME
  Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy.; Journal of immunotherapy (Hagerstown, Md. : 1997); Vol 33(5). 2010 Jun.